Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:39 PM
Ignite Modification Date:
2025-12-24 @ 2:39 PM
NCT ID:
NCT05256459
Eligibility Criteria:
Inclusion Criteria:
* Willing and able to sign informed consent
* Male or female, 18 ≤ age≤ 75
* The diagnosis was in accordance with the 2019 guidelines for the diagnosis and treatment of chronic hepatitis B and received anti HBV treatment for 48 weeks;
* Imaging examination showed liver nodules or space occupying lesions (any imaging examination of abdominal color Doppler ultrasound, CT and MRI), and imaging examination could not determine the benign and malignant of the lesions
* The estimated survival time is more than half a year
* Peripheral blood cfdna gene screening is high risk
* Full capacity for civil conduct
Exclusion Criteria:
* Primary liver cancer was diagnosed or supported by the following evidence: elevated alpha fetoprotein (AFP \> 100ng / ml) or liver imaging showed clear liver cancer nodules in the liver
* Have a history of malignant tumors within 5 years before screening, except for specific cancers cured by surgical resection (such as basal cell skin cancer, etc.)
* Current or previous history of major diseases that may interfere with personal treatment, evaluation or compliance. Major diseases are 25 major diseases specified by the CIRC
* Combined with HCV, HIV, HDV or other infectious diseases
* Severe lung disease, severe heart disease or genetic metabolic disease
* Psychiatric hospitalization, attempted suicide and / or temporary disability due to mental illness in the past 5 years
* Combined with autoimmune liver disease, alcoholic liver disease and drug-induced liver injury
* Pregnant or lactating women
* The researcher believes that it is not suitable to participate in this experiment.
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05256459
Study Brief:
Protocol Section:
NCT05256459